AstraZeneca announces insitro collaboration as AstraZeneca stock trades at EUR 146.33
Published on 10/18/2026 at 18:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSCollaboration and session dates
- AstraZeneca announced an insitro collaboration on October 15, 2026.
- AstraZeneca stock trades in weekend trading at Lang & Schwarz at EUR 146.33 at 5:58 p.m. CEST on October 18, 2026.
- The next Xetra session is scheduled for October 19, 2026.
AstraZeneca announced a new strategic collaboration with insitro on October 15, 2026, to use advanced artificial intelligence systems to develop therapeutics for difficult-to-treat cardiometabolic diseases, according to the company’s Media Centre. At Lang & Schwarz, AstraZeneca stock was at EUR 146.33 in weekend trading at 5:58 p.m. CEST on October 18, 2026.
Market context: Market report FTSE 100.
The week in figures
The Lang & Schwarz price was EUR 146.33 at 5:58 p.m. CEST on October 18, 2026. The quote reflects weekend trading in euros.
Chronology of the week
On October 11, 2026, AstraZeneca reported that efzimfotase alfa showed a numerical improvement in the Six-Minute Walk Test in the HICKORY Phase III trial. The company reported a mean difference of 17.05 meters versus placebo at week 25, according to its Media Centre.
On October 15, 2026, AstraZeneca announced the strategic collaboration with insitro for artificial-intelligence-supported cardiometabolic therapeutics, the company said in its Media Centre.
Dates of the coming week
The next Xetra session is scheduled for October 19, 2026. The further course of weekend trading at Lang & Schwarz until 7:00 p.m. CEST is shown by the continuously updated real-time quote of AstraZeneca stock.
